Align Technology (ALGN) Total Non-Current Liabilities (2009 - 2026)
Align Technology (ALGN) posted quarterly Total Non-Current Liabilities of $2.1 billion for Q1 2026, down 6.89% year-over-year from $2.2 billion in Q1 2025, and down 2.82% quarter-over-quarter from $2.1 billion in Q4 2025.
Align Technology (ALGN) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Align Technology (ALGN) has reported Total Non-Current Liabilities for 18 consecutive years, with $2.1 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 6.89% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $2.1 billion (down 6.89% YoY), while the FY2025 annual figure was $2.1 billion, down 4.79% from the prior year.
- Total Non-Current Liabilities eased to $2.1 billion in Q1 2026 per ALGN's latest filing, from $2.1 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $2.4 billion in Q2 2023 and bottomed at $2.1 billion in Q1 2026.
- Historically, Total Non-Current Liabilities has averaged $2.2 billion across 5 years, with a median of $2.2 billion in 2025.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 33.55% — and 2026, when it decreased 6.89%.
- Align Technology's Total Non-Current Liabilities stood at $2.2 billion in 2022, then grew by 6.03% to $2.3 billion in 2023, then decreased by 2.53% to $2.2 billion in 2024, then retreated by 4.79% to $2.1 billion in 2025, then retreated by 2.82% to $2.1 billion in 2026.
- Business Quant data shows ALGN's Total Non-Current Liabilities at $2.1 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.2 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 2.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.07 Bn |
| Mar 31, 2026 | 2.06 Bn |
| Dec 31, 2025 | 2.12 Bn |
| Sep 30, 2025 | 2.17 Bn |
| Jun 30, 2025 | 2.19 Bn |
| Mar 31, 2025 | 2.21 Bn |
| Dec 31, 2024 | 2.22 Bn |
| Sep 30, 2024 | 2.31 Bn |
| Jun 30, 2024 | 2.30 Bn |
| Mar 31, 2024 | 2.24 Bn |
| Dec 31, 2023 | 2.28 Bn |
| Sep 30, 2023 | 2.34 Bn |
| Jun 30, 2023 | 2.39 Bn |
| Mar 31, 2023 | 2.29 Bn |
| Dec 31, 2022 | 2.15 Bn |
| Sep 30, 2022 | 2.09 Bn |
| Jun 30, 2022 | 2.09 Bn |
| Mar 31, 2022 | 2.09 Bn |
| Dec 31, 2021 | 2.20 Bn |
| Sep 30, 2021 | 1.99 Bn |